Asthma and Pregnancy Toolkit

Breathe 4 Baby

Asthma and allergic diseases are the most common medical conditions faced during pregnancy. Asthma prevalence in pregnancy is 8-9% and increasing. Pregnant patients with asthma have an increased risk for perinatal complications including preterm birth, low birth weight, and pre-eclampsia. Severe asthma in pregnancy is a cause of mortality. Optimal asthma management in pregnancy is associated with improved outcomes in maternal and fetal health.

The Breathe 4 Baby Toolkit is a resource for educating patients and providers regarding asthma prevalence, diagnosis, and management in pregnancy to improve outcomes for pregnant patients with asthma and their babies. This includes the Pregnancy and Lactation Asthma Plan, the validated pregnancy ACT (p-ACT), and other educational resources.

Pregnancy and Lactation Asthma Plan
PLAN DE ACCIÓN CONTRA EL ASMA DURANTE EL EMBARAZO Y LA LACTANCIA (Pregnancy and Lactation Asthma Plan)

Pregnancy Asthma Control Test
PRUEBA DE CONTROL DEL ASMA DURANTE EL EMBARAZO (Pregnancy Asthma Control Test)

This toolkit was created by the Vaccines and Medications in Pregnancy Safety Studies Taskforce (VAMPSS), and the Women’s Health in A/I Committee in collaboration with the Asthma and Allergy Foundation of America (AAFA).

Mother To Baby resources page

Basics Of Asthma and Pregnancy

Asthma Medication Fact Sheets - The effect on pregnancy/lactation, birth defects, fertility.
Albuterol
Prednisone
ICS
Montelukast
Salmeterol
Formoterol
Dupilumab
Benralizumab
Mepolizumab

Safety data for biologics used for asthma and allergic diseases during pregnancy

Breathing for two: Managing asthma during pregnancy

Asthma in Pregnancy Toolkit  - Australia

AAAAI Resources

Article on asthma and pregnancy. (includes podcast)

Article on asthma, allergies and pregnancy. (includes podcast)

Asthma Overview in basic language for patients. Includes symptoms, diagnosis and treatment.

Inhaled Asthma Medications

Biologics Basics

Episode 164: Navigating Allergy, Asthma and Biologics in Pregnancy 

Join us as Monica Kraft, MD, FAAAAI, provides an evidence-based framework for managing allergic conditions during pregnancy, focusing on the safety of commonly used medications, from inhaled corticosteroids and antihistamines to biologics. We address the risks of undertreated asthma and explore the latest recommendations for penicillin allergy delabeling to optimize maternal-fetal outcomes. The discussion offers practical strategies for collaborating with OB-GYN colleagues to ensure safe, effective treatment throughout every trimester. (June 9, 2026)

Listen to the podcast and view transcript.

View the Work Group Report: Penicillin Allergy Delabeling Can and Should Be Performed in Pregnant Patients: A Work Group Report of the AAAAI Women’s Health in Allergy and Immunology and Adverse Reaction to Drugs, Biologics and Vaccines Committees

Why Should Pregnant Patients with a Penicillin Allergy Label Be Tested?

Why Penicillin Allergy Evaluation is Important for You and Your Baby?